Table 1

Baseline patient characteristics

Mean (SD)

Median (range)


Age (years)

74 (5.1)

74 (65–80)

KPS

87.7 (9.7)

90 (70–100)

Hemoglobin (g/dl)

12.1 (1.3)

12.1 (10.0–14.3)

PSA (ng/ml)

665 (1230)

218.3 (9–5754)

Alkaline phosphatase (U/l)

223 (208)

126.5 (51–768)

Duration of androgen deprivation (months)

65.8 (36.3)

60 (8–132)

Secondary hormonal manipulations

2.4 (1.5)

2 (0–5)

Primary Therapy

Number

Prostatectomy

13

Prostatectomy and radiation

7

Radiation alone

2

Androgen-deprivation therapy alone

7

Sites of Disease

Bone only

14

Visceral only

2

Both

6


Gross et al. BMC Cancer 2007 7:142   doi:10.1186/1471-2407-7-142

Open Data